Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Express Scripts
AstraZeneca
Merck
McKesson

Last Updated: September 26, 2022

Santen Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Santen
International Patents:94
US Patents:6
Tradenames:4
Ingredients:3
NDAs:4

Drugs and US Patents for Santen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Santen VERKAZIA cyclosporine EMULSION;OPHTHALMIC 214965-001 Jun 23, 2021 RX Yes Yes 9,956,289 See Plans and Pricing Y See Plans and Pricing
Santen IQUIX levofloxacin SOLUTION/DROPS;OPHTHALMIC 021571-001 Mar 1, 2004 DISCN Yes No See Plans and Pricing See Plans and Pricing
Santen VERKAZIA cyclosporine EMULSION;OPHTHALMIC 214965-001 Jun 23, 2021 RX Yes Yes 8,524,779 See Plans and Pricing Y See Plans and Pricing
Santen VERKAZIA cyclosporine EMULSION;OPHTHALMIC 214965-001 Jun 23, 2021 RX Yes Yes 8,298,568 See Plans and Pricing Y See Plans and Pricing
Santen ALAMAST pemirolast potassium SOLUTION/DROPS;OPHTHALMIC 021079-001 Sep 24, 1999 DISCN No No See Plans and Pricing See Plans and Pricing
Santen VERKAZIA cyclosporine EMULSION;OPHTHALMIC 214965-001 Jun 23, 2021 RX Yes Yes 9,132,071 See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Santen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Santen ALAMAST pemirolast potassium SOLUTION/DROPS;OPHTHALMIC 021079-001 Sep 24, 1999 5,034,230*PED See Plans and Pricing
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 4,551,456 See Plans and Pricing
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 4,382,892 See Plans and Pricing
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 5,053,407 See Plans and Pricing
Santen IQUIX levofloxacin SOLUTION/DROPS;OPHTHALMIC 021571-001 Mar 1, 2004 5,053,407 See Plans and Pricing
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 5,503,407 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for Santen Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2049079 PA2017003,C2049079 Lithuania See Plans and Pricing PRODUCT NAME: CIKLOSPORINAS; REGISTRATION NO/DATE: EU/1/15/990 20170319
1809237 C01809237/01 Switzerland See Plans and Pricing PRODUCT NAME: CICLOSPORIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66093 08.09.2016
1809237 300741 Netherlands See Plans and Pricing PRODUCT NAME: CICLOSPORINE (EYE DROP EMULSION); REGISTRATION NO/DATE: EU/1/15/990 20150323
2049079 LUC00006 Luxembourg See Plans and Pricing PRODUCT NAME: CYCLOSPORINE (GOUTTES OCULAIRES SOUS FORME D'EMULSION); AUTHORISATION NUMBER AND DATE: EU/1/15/990 20150323
0206283 SPC/GB97/085 United Kingdom See Plans and Pricing PRODUCT NAME: LEVOFLOXACIN, OPTIONALLY IN THE FORM OF A HEMIHYDRATE; REGISTERED: UK 13402/0011 19970606; UK 13402/0012 19970606; UK 13402/0013 19970606
1809237 122015000043 Germany See Plans and Pricing PRODUCT NAME: OPHTHALMISCHE EMULSION ENTHALTEND CYCLOSPORIN; REGISTRATION NO/DATE: EU/1/15/990 20150319
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Boehringer Ingelheim
Harvard Business School
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.